What is the Bionano Genomics Inc. stock price forecast?

Bionano Genomics Inc. is currently trading at $1.16. View real-time AI analysis on Alpha Lenz.

What is Bionano Genomics Inc. insider trading activity?

View the latest insider trading data for Bionano Genomics Inc. on Alpha Lenz.

What is Bionano Genomics Inc.'s P/E ratio?

Bionano Genomics Inc.'s P/E ratio is -0.2.

Bionano Genomics Inc.

NASDAQ · BNGO

$1.16-0.03(-2.52%)Pre-market

Ask about Bionano Genomics Inc.'s future dividend policy...

Alpha Chat Insight

“Bionano Genomics Inc. trades at a P/E of -0.2 (undervalued) with modest ROE of -66.2%.”

Ask for details →

Company Overview

Bionano Genomics Inc. is a life sciences instrumentation company specializing in decoding the genome for biomedical research, diagnostics, and personalized medicine applications. The company's primary focus is its proprietary Saphyr system, an advanced platform designed to analyze the structural variations of DNA on a large scale. This system supports researchers and clinicians in detecting genetic diseases, cancer-causing mutations, and other genomic variations that traditional sequencing methods may overlook. Bionano Genomics' technology offers high throughput and resolution, making it an invaluable tool in genomics labs and research institutions. The company's contributions are pivotal in the fields of genetic research and diagnostics, where precise insights into the genome pave the way for breakthroughs in understanding complex genetic disorders. By facilitating a deeper comprehension of the human genome, Bionano Genomics plays a crucial role in advancing genomic medicine and improving patient outcomes through more personalized and effective therapies.

CEODr. Robert Erik Holmlin M.B.A., Ph.D.

Websitehttps://www.bionano.com

SectorHealthcare

IndustryMedical Instruments & Supplies

Employees344

Company Statistics

FY 2025

Profile

$6.32MMarket Cap

$28.51MRevenue

0.00Shares Out

344Employees

Margins

46.25%Gross

-57.17%EBITDA

-116.95%Operating

-92.35%Pre-Tax

-92.59%Net

Valuation

-0.24P/E

0.14P/B

0.22EV/Sales

-0.63EV/EBITDA

-0.39P/FCF

Growth (CAGR)

0.84%Rev 3Yr

27.37%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-35.13%ROA

-66.15%ROE

-34.65%ROIC

Financial Health

$2.99MCash & Cash Equivalents

$26.17MNet Debt

65.64%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Bionano Genomics Inc. trades at a P/E of -0.2 (undervalued) with modest ROE of -66.2%.”

Ask for details →

Frequently Asked Questions

Bionano Genomics Inc. (ticker: BNGO) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 344 employees. Market cap is $6M.

The current price is $1.16 with a P/E ratio of -0.24x and P/B of 0.14x.

ROE is -66.15% and operating margin is -116.95%. Annual revenue is $29M.